πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Pipeline programs

Browse 12,558 clinical pipeline programs from ClinicalTrials.gov, linked to pharma companies. Phase, modality, and trial IDs for BD teams.

12,558 programs 407 companies
project

ALX1-11

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 Β· small_molecule Β· completed

1 trials
project

ALX1-11 (drug)

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 Β· small_molecule Β· completed

1 trials
project

ALXN2060

BridgeBio Oncology Therapeutics

Phase 3 Β· small_molecule Β· completed

1 trials
project

AMG 479

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 Β· small_molecule Β· completed

1 trials
project

AMG 706

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 Β· small_molecule Β· terminated

1 trials
project

AMPHORA

Evofem Biosciences

Phase 3 Β· small_molecule Β· completed

1 trials
project

AMX0035

Amylyx Pharmaceuticals

Phase 3 Β· small_molecule Β· active

5 trials
project

AMX0035

Amylyx Pharmaceuticals

Phase 3 Β· small_molecule Β· completed

1 trials
project

APF530

HERON THERAPEUTICS, INC. /DE/

Phase 3 Β· small_molecule Β· completed

1 trials
project

APF530

HERON THERAPEUTICS, INC. /DE/

Phase 3 Β· small_molecule Β· completed

1 trials
project

APL-2

Apellis Pharmaceuticals

Phase 3 Β· small_molecule Β· completed

1 trials
project

APL-2

Apellis Pharmaceuticals

Phase 3 Β· small_molecule Β· completed

2 trials
project

APL-2, Pegcetacoplan

Apellis Pharmaceuticals

Phase 3 Β· small_molecule Β· completed

1 trials
project

APL2

Apellis Pharmaceuticals

Phase 3 Β· small_molecule Β· active

1 trials
project

APR-246 + azacitidine

Aprea Therapeutics

Phase 3 Β· small_molecule Β· completed

1 trials
project

ARALAST NP 60 mg/kg

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 Β· mab Β· terminated

1 trials
project

ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine

Arcturus Therapeutics Holdings

Phase 3 Β· mab Β· completed

1 trials
project

ARCT-2303

Arcturus Therapeutics Holdings

Phase 3 Β· mab Β· completed

1 trials
project

ARD-101

Aardvark Therapeutics

Phase 3 Β· small_molecule Β· on_hold

1 trials
project

ARQ-151 0.3% cream

Arcutis Biotherapeutics

Phase 3 Β· small_molecule Β· completed

1 trials
project

ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%

Arcutis Biotherapeutics

Phase 3 Β· small_molecule Β· completed

1 trials
project

ASCs (Cx401, company code)

TAKEDA PHARMACEUTICAL CO LTD

Phase 3 Β· small_molecule Β· completed

1 trials
project

ATLG

China SXT Pharmaceuticals

Phase 3 Β· small_molecule Β· active

1 trials
project

AXS-02

Axsome Therapeutics

Phase 3 Β· small_molecule Β· active

1 trials